Trastuzumab 150mg CANMAb Injection
Breast cancer Stomach cancer
| Product | Trastuzumab 150mg CANMAb Injection |
|---|---|
| Used for | Breast cancer Stomach cancer |
| Dosage form | Injection |
| Pack | Standard manufacturer pack |
| Manufacturer | Biocon |
| Composition | Trastuzumab |
| Strength | 150 mg |
| Pack size | 1ml |
| Shelf life | 3 Years |
| Storage | Refrigerate at 2–8°C. Do not freeze. |
| Country of origin | India |
No payment is taken on this site. We reply with price, batch, expiry and shipping cost. Ask about this product on WhatsApp
Trastuzumab 150mg CANMAb Injection is a injection in our Oncology range, used for breast cancer stomach cancer.
Canmab 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein). Canmab 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Hormonal therapy, kinase inhibitors and CDK4/6 inhibitors for breast, prostate, lung, kidney and brain cancers.
This is a prescription medicine and must be used under the supervision of a registered medical practitioner.
